John Dorfman: CEOs buy shares at Pfizer, Uber

Watching the trades of company chief executive officers is a fascinating sport. It also can be profitable. Here are some ...
24/7 Wall St.

Pfizer’s 6% Yield Masks a Fragile Dividend Story

Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the balance sheet leaves ...
Time

Pfizer CEO Albert Bourla on Making Medicine in the U.S., Vaccines After COVID, and How He Gets Along With RFK Jr.

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
Wall Street Journal

Pfizer CEO Says Digging Out of Post-Covid Hole Will Take a Few More Years

Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...
WRAL

Pfizer’s Departing CEO Will Be Known for the Deals He Didn’t Complete

Ian Read is stepping down after eight years as chief executive of Pfizer. During his tenure, Read helped reshape one of the world’s biggest pharmaceutical companies. Through deal-making, he focused ...